Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Boston Scientific (NY:BSX)

101.11 -1.28 (-1.25%)
Official Closing Price Updated: 7:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares... 
Via MarketMinute
Topics Earnings Supply Chain
What the Options Market Tells Us About Boston Scientific
 
Via Benzinga
BSX Q3 Deep Dive: WATCHMAN and Electrophysiology Drive Outperformance, Guidance Raised
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q3 CY2025, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s revenue was... 
Via StockStory
Topics World Trade
Boston Scientific To Acquire Privately-Held Pain Solutions Developer Nalu Medical For About $533M
Via Stocktwits
These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings
 
Via Benzinga
Top S&P500 movers in Wednesday's session
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance. 
Via Benzinga
Tech Stocks Drop, Netflix Sinks 10% On Worst Day Since 2022: What's Moving Markets Wednesday?
Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence. 
Via Benzinga
Topics World Trade
Boston Scientific (BSX) Stock Is Up, What You Need To Know
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.4% in the morning session after the company reported strong third-quarter results that topped Wall Street's forecasts and raised... 
Via StockStory
Topics Artificial Intelligence
Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growth
Boston Scientific Q3 revenue hit $5.07 billion, beating forecasts. The company raised its full-year guidance based on strong segment growth. 
Via Benzinga
Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market
Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Boston Scientific Jumps On Third-Quarter Beat, Strong Guide
Boston Scientific stock jumped early Wednesday on a strong 2025 outlook following its third-quarter sales and earnings beat. 
Via Investor's Business Daily
Boston Scientific Corp (NYSE:BSX) Reports Strong Q3 2025 Earnings, Beats Estimates
Boston Scientific beats Q3 2025 earnings and revenue forecasts, reporting strong sales growth and issuing optimistic Q4 guidance. 
Via Chartmill
Topics Earnings
Beware The Death Cross: 3 Stocks Triggering This Spooky Signal
The Death Cross is something you never want to see on a stock you own. Take caution with these three companies that recently were visited by this scary signal. 
Via MarketBeat
Topics ETFs
Boston Scientific’s (NYSE:BSX) Q3 Sales Top Estimates
Medical device company Boston Scientific (NYSE:BSX) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $5.07 billion. Guidance for next quarter’s... 
Via StockStory
What to Expect from Boston Scientific's Earnings
 
Via Benzinga
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company Boston Scientific (NYSE:BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For October 22, 2025
 
Via Benzinga
21 Analysts Have This To Say About Boston Scientific
 
Via Benzinga
Boston Scientific's Options: A Look at What the Big Money is Thinking
 
Via Benzinga
Boston Scientific To Acquire Nalu Medical In $600 Million Pain Relief Deal
Boston Scientific Corp (NYSE: BSX) to acquire Nalu Medical Inc. for $600 million in cash. Deal expected to close in first half of 2026. 
Via Benzinga
$1000 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
1 Profitable Stock with Promising Prospects and 2 We Find Risky
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Topics Economy
2 S&P 500 Stocks to Target This Week and 1 Facing Challenges
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
1 Cash-Producing Stock for Long-Term Investors and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Topics Intellectual Property
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
In today's session, there are S&P500 stocks with remarkable trading volume.
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session. 
Via Chartmill
Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.